The karyotypes of the bat species Molossus ater, M. molossus (2n = 48; NF = 64) and Molossops planirostris (2n = 34; NF = 60) were analyzed by G-, C-banding, silver nitrate staining (AgNO3), base-specific fluorochromes and fluorescent in situ hybridization (FISH). The two species of Molossus presented the constitutive heterochromatin (CH) in the pericentromeric regions of all autosomes and in the X chromosome, while the Y chromosome was completely heterochromatic. Molossops planirostris showed conspicuous CH blocks in the pericentromeric regions of the pairs 4, 5, 8, 15, 16 and in the short arm of the X chromosome, while the Y did not present any CH block. Pretreated slides for C-banding stained with DAPI (CB-DAPI) revealed a similar pattern of C-banding (CBG) for these species. Sequential staining (AgNO3/CMA3/DAPI) in M. planirostris showed that the nucleolus organizer regions (NORs) are weakly CMA3 positive and DAPI negative. In the three species, triple staining with CMA3/DA/DAPI revealed R-banding with CMA3 and uniform staining with DAPI. The ribosomal cistrons detected by FISH were present only in the pair 5 in both species of Molossus, and in two pairs of medium sized chromosomes (pairs 9 and 10) of Molossops planirostris. The results obtained by FISH, compared with those by AgNO3 staining, indicated that all NORs in these species are transcriptionally active.

The brown seaweed Fucus vesiculosus (Fucales, Fucaceae) was screened for its protective activity using doxorubicin-induced DNA damage in human lymphocytes. In this study, we assessed the genotoxic and antigenotoxic potential of three different concentrations (0.25, 0.5 and 1.0 mg mL -1 ) of F. vesiculosus aqueous extract using the chromosome aberration and Comet assays. Treatment of human lymphocyte cultures with 0.25, 0.5 and 1.0 mg mL -1 F. vesiculosus aqueous extract had no effect on the chromosome aberration frequency or on the extent of DNA damage detected by the Comet assay. The antigenotoxic effects of the extract were tested in human lymphocyte cultures treated with 15 μg mL -1 of doxorubicin, either alone or combined with the different concentrations of the extract, which was added to the cultures before, simultaneously with or after the doxorubicin. Only when lymphocytes were pre-treated with extract there was a reduction in doxorubicin-induced chromosome aberrations and DNA damage as detected by the Comet assay. These results demonstrate that F. vesiculosus aqueous extract is not genotoxic in cultured human lymphocytes and indicate that when added to lymphocyte cultures before doxorubicin it has antigenotoxic activity against doxorubicin-induced DNA damage.